The Latest Cardiac and Vascular News
LOS ANGELES–(BUSINESS WIRE)–Non-invasive cardiac assessment company Sensydia announced today that it has completed its 50-subject development study at the University of Minnesota (UMN). This study was conducted at UMN to collect data for its innovative AI-powered, non-invasive Cardiac Performance System (CPS™) that uses heart sound analysis to enable earlier detection and more effective therapy guidance for patients suffering from […]
NIH STTR Fast-Track grant helps propel Sensydia’s non-invasive CPS platform building on recent funding round LOS ANGELES–(BUSINESS WIRE)–Non-invasive cardiac diagnostic company Sensydia announced today that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). The award provides Sensydia with non-dilutive funding for […]
Sensydia continues to push the boundaries of AI in heart function assessment LOS ANGELES–(BUSINESS WIRE)–Non-invasive cardiac assessment company Sensydia today announced it has raised approximately $8M in new funding from an expanded syndicate of investors. Proceeds of the financing will enable the company to prepare for commercialization of its groundbreaking non-invasive cardiac assessment platform, Cardiac Performance System (CPS™). […]
— Completion of enrollment for this 225-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate measurement of pulmonary pressure — LOS ANGELES–(BUSINESS WIRE)–Non-invasive cardiac assessment company Sensydia announced today that it has completed its 225-subject development study at the University of Pittsburgh Medical Center (UPMC). This study was conducted at […]
– External device uses heart sound and AI to deliver rapid cardiac function assessments via tablet to expand hemodynamic evaluation beyond the Cath lab – LOS ANGELES–(BUSINESS WIRE)–Sensydia, an innovator in rapid, non-invasive measurement of critical cardiac function, today announced that its Cardiac Performance System (CPSTM) has been granted Breakthrough Device Designation by the United States Food and Drug […]
LOS ANGELES–(BUSINESS WIRE)–Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function, announced that industry leader Anthony Arnold has been appointed as chief executive officer and president and joins the Board of Directors. Arnold is a pioneer in bioelectronic medicine and surgical navigation and brings more than 20 years of leadership experience from a range […]
